These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37792220)

  • 1. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
    Dadey DYA; Medress ZA; Sharma M; Ugiliweneza B; Wang D; Rodrigues A; Parker J; Burton E; Williams B; Han SS; Boakye M; Skirboll S
    J Neurooncol; 2023 Sep; 164(3):655-662. PubMed ID: 37792220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second Primary Malignancies following a Diagnosis of Conjunctival Melanoma.
    Mahjoub H; Loya A; Ayaz T; Weng CY
    Curr Eye Res; 2022 Apr; 47(4):634-641. PubMed ID: 34898336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
    Farr DE; Thomas A; Khan SA; Schroeder MC
    Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study.
    Joshi U; Bhattarai A; Gaire S; Gill S; Agrawal V; Yadav SK; Low SK; Dhakal P; Bhatt VR; Kouides PA
    Leuk Lymphoma; 2022 Dec; 63(14):3456-3461. PubMed ID: 36120968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z; Liu L; Leng K; Shi G
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary malignancies after ocular adnexal lymphoma diagnosis.
    Loya A; Ramachandran V; Ayaz T; Weng CY
    BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
    Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
    BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Risk of Subsequent Malignant Neoplasms Among Childhood and Adolescent Lymphoma Survivors (1975-2013): A Population-Based Predictive Nomogram.
    Liu J; Zheng Q; Beeraka NM; Zhang X; Li T; Song R; Zhao D; Fan R
    Oncologist; 2023 Sep; 28(9):e765-e773. PubMed ID: 37177980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
    Eid E; Maloney NJ; Cai ZR; Zaba LC; Kibbi N; John EM; Linos E
    JAMA Dermatol; 2023 Nov; 159(11):1248-1252. PubMed ID: 37703005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
    Wei JL; Jiang YZ; Shao ZM
    Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Second Primary Tumors After Childhood and Adolescent Ovarian Malignancies: A SEER Analysis (1973-2011).
    Nasioudis D; Ramer I; Sisti G; Fambrini M
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):522-5. PubMed ID: 26152647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X; Wang X; Wei L; Liu J; Chen M
    Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.